Navigation

Fidaxomicin May Be Best Choice for C. difficile

By David Douglas (Reuters Health) | on August 7, 2018 | 0 Comment

Pages: 1 2 | Single Page

Topics: C. difficile Fidaxomicin infection Quality & Safety

No Responses to “Fidaxomicin May Be Best Choice for C. difficile”

Leave a Reply Cancel Reply

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603